News Digest 22.11.2023-24.11.2023
Regulators
Roszdravnadzor spoke about the reason for suspending the use of Botkin.AI
The decision of Roszdravnadzor to suspend the use of the Botkin.AI platform for processing and analyzing medical images using artificial intelligence is due to deviations in the characteristics of this medical product relative to those declared during its state registration. The department's press service reported this to TASS. The Kommersant newspaper reported the suspension of Botkin.AI on Tuesday. As the press service of Roszdravnadzor clarified to TASS, the agency has planned an inspection against the manufacturer of this platform.
Source: https://tass.ru/obschestvo/19341423
Market news
105 medical projects included in the TOP 1000 technology startups
The Ministry of Education and Science of the Russian Federation has published the results of the ranking of the best startups in the country. Among medical universities, the project of Sechenov University student Maxim Suchkov called Save My Milk received the highest rating - 15th, and in total there are 105 startups related to healthcare in the ranking. The student's development is a device for express disinfection of expressed breast milk, which allows preparing food for delayed feeding of the child and safe storage at home.
FEFU has developed an anti-tremor non-invasive neurostimulator
Scientists from the Far Eastern Federal University (FEFU) conducted the first tests of a prototype anti-tremor non-invasive neurostimulator on five patients with Parkinson's disease and essential tremor. The device can reduce tremors by up to 80%. The neurostimulator is the first domestic device of this type. It allows you to suppress tremors without surgery or drug therapy. At this stage of development, according to bioengineer Alexander Artemenko, positive dynamics can be observed, but the indicators of tremor activity decrease in each case by an individual percentage. Scientists from FEFU plan to conduct additional research to improve the stability of the results. Also, by the time the device is released on the market, the creators want to reduce the size of the neurostimulator to the size of a wristwatch. The estimated release date of the device is 2025. The development of an anti-tremor neurostimulator is carried out with the support of the Priority 2030 program. According to the leading neurosurgeon of the FEFU Medical Complex, Artur Biktimirov, there is only one analogue of the device under development in the world, produced in the USA.
Rostec began clinical testing of the HIFU therapy complex DIATER-M
Clinical testing will take place in two stages and will last about six months. The developer, the Shvabe holding and the Novosibirsk Instrument-Making Plant, plans to obtain the first results in the summer of 2024. After this, the medical complex will be put into mass production. HIFU is used to treat and remove tumors without surgery, which significantly reduces the rehabilitation period for patients. This method is considered one of the safest in the world. It does not require anesthesia or the administration of strong drugs. HIFU therapy can be carried out even if the patient has metal braces, various implants and metal structures in the body.
Chelyabinsk OFAS canceled the purchase of 100 million rubles for clothing for medical workers
The Federal Antimonopoly Service of the Chelyabinsk Region ordered the regional Ministry of Health to cancel a purchase worth 99.9 million rubles to find a contractor for sewing clothing for doctors due to “significant violations of the law.” The customer required about 5 thousand medical suits for 35 medical institutions in the same style. A complaint about the tender was filed by the All-Russian Society of the Deaf, which is applying for a government contract. According to the society, which supported the OFAS, the customer determined the terms of the purchase in such a way that the deaf society was not able to take part in the auction. The service also noted: “it is impossible to make an unambiguous conclusion about what needs to be done as part of the provision of this service.”
Source: https://chel.fas.gov.ru/news/39517
Other
The National Medical Research Center for Coloproctology has created an AI technology to detect colorectal cancer
National Medical Research Center of Coloproctology named after. A.N. Ryzhikh has developed technology based on artificial intelligence (AI) to detect colorectal cancer, the press service of the Ministry of Health said. Directly during an endoscopic examination of the colon (colonoscopy), the ArtInCol system, using machine vision, detects even the most inconspicuous neoplasms, which allows the doctor to pay attention to them, conduct additional diagnostics, and, if possible, immediately remove them through a colonoscope. This will facilitate the work of endoscopists and, ultimately, reduce the morbidity and mortality from colorectal cancer, explained Sergei Achkasov, director of the National Medical Research Center. The AI software is domestic, developed jointly with the Russian company Alnisoft. It can be built into any endoscopy stand.
New registered medical devices
We are publishing a list of new medical devices registered from 11/17/2023 to 11/24/2023
https://cont.asiamc.ru/uploads/blogs/2023-11-24/6560f8eb59920.pdf
News
